Current Articles | Syndication

Lab M installs a Gericke cone mill As specialists in the development and production of microbiological culture media, Lab M had a very particular list of requirements when they chose to increase production capacity with an additional grinding mill.The GCN-150 Cone Mill was Lab M’s system of choice.

Stockport Pharmacies Provide Point of Care Testing to Improve Service for Diabetic Patients Ten pharmacies in the Stockport area have been supplied with Siemens DCA Vantage Analysers in order to offer an HbA1c test to appropriate diabetes patients, as part of a pharmacy Point of Care testing project.

Radiometer adds NT-proBNP and Troponin T to AQT90 FLEX Assays for NT-proBNP and Troponin T have been added to the panel of cardiovascular markers that can be assessed at the point of care using Radiometer’s new AQT90 FLEX POC immunoassay platform.

Oxoid kits for detection of staphylococcal exotoxins - Toxic Shock Syndrome update Oxoid RPLA Toxin Detection Kits allow the presence of soluble antigen, such as bacterial toxins, to be detected visually by the agglutination of antibody-coated latex particles.

Siemens celebrate 50,000 placement of Clinitek Analyser In October 2008 the 50,000th Siemens Clinitek Status urine analyser been installed in the Children’s Ward and Teenage Unit at Frimley Park Hospital in Surrey. Photo Caption: Left to right: Dr Abdus Mallik, consultant paediatrician, Trevor Allison, Siemens and Children's Ward Sister Gail Ashworth at the handover of the 50,000th Siemens Clinitek Status analyser

Myconostica Appoints Experienced Diagnostics Executive John Garland as CEO Myconostica Ltd, a UK Manchester-based medical diagnostic company which specialisesin rapid and highly specific tests for life-threatening fungal infections, today announces the appointment of John Garland as Chief Executive Officer commencing November 10th 2008.

Myconostica Appoints Experienced Diagnostics Executive John Garland as CEO Myconostica Ltd, a UK Manchester-based medical diagnostic company which specialisesin rapid and highly specific tests for life-threatening fungal infections, today announces the appointment of John Garland as Chief Executive Officer commencing November 10th 2008.

Myconostica Appoints Experienced Diagnostics Executive John Garland as CEO Myconostica Ltd, a UK Manchester-based medical diagnostic company which specialisesin rapid and highly specific tests for life-threatening fungal infections, today announces the appointment of John Garland as Chief Executive Officer commencing November 10th 2008.

Myconostica Appoints Experienced Diagnostics Executive John Garland as CEO Myconostica Ltd, a UK Manchester-based medical diagnostic company which specialisesin rapid and highly specific tests for life-threatening fungal infections, today announces the appointment of John Garland as Chief Executive Officer commencing November 10th 2008.

Myconostica Appoints Experienced Diagnostics Executive John Garland as CEO Myconostica Ltd, a UK Manchester-based medical diagnostic company which specialisesin rapid and highly specific tests for life-threatening fungal infections, today announces the appointment of John Garland as Chief Executive Officer commencing November 10th 2008.

Paging - Page: 1 of 11 Previous Page | Next Page